Skip to main content
. Author manuscript; available in PMC: 2021 Jul 24.
Published in final edited form as: Nutr Metab Cardiovasc Dis. 2020 Apr 21;30(8):1375–1381. doi: 10.1016/j.numecd.2020.04.012

Table 1.

Baseline Characteristics Among Randomized Study Participants

Baseline Characteristics Endurance Exercise/Caloric Restriction Usual Activity/Caloric Restriction Endurance Exercise/Usual Diet Usual Activity/Usual Diet
N 30 28 27 26
Age, years 52.9 (8.6) 55.6 (12.6) 54.5 (11.7) 57.3 (9.7)
Race
 White 22(73.3) 19(67.9) 17(63) 16(61.5)
 Black 7(23.3) 9(32.1) 7(25.9) 8(30.8)
 Other 1(3.3) 0(0) 3(11.1) 2(7.7)
Male Gender 17(56.7) 15(53.6) 15(55.6) 17(65.4)
BMI, kg/m2 34 (6.7) 33.5 (7.3) 32.5 (5.8) 38.8 (11.9)
Waist circumference, in 43.9 (5.9) 43.3 (6) 42 (5.1) 46.5 (7.6)
Hip circumference, in 46.3 (6) 45.9 (5.3) 45.1 (4.5) 49 (7.9)
Systolic BP, mmHg 124.7 (17.7) 132 (22.8) 129.9 (18.6) 131.3 (16.9)
Weekday energy intake, kcal 1769 (691) 1619 (549) 1669 (577) 1738 (657)
Weekend energy intake, kcal 1787 (649) 1561 (466) 1765 (583) 1859 (763)
DEXA body fat, % 40.6 (7.4) 40.4 (8.5) 40.2 (7.6) 40 (8.1)
BIA body fat % 35.6 (10.5) 35 (10.7) 34.3 (8.7) 36 (10.2)
Physical Activity, counts per minute 868 (408, 1765) 616 (290, 1271) 850 (529, 3065) 888 (349, 1723)
Percent time spent
 in sedentary time 72.2 (16.1) 69.5 (14) 70 (13.8) 77 (13.8)
 in light activity 22 (11.8) 25.5 (10.4) 24.3 (11.8) 19.1 (12)
 in moderate activity 3 (2.4) 2.9 (4.1) 3.7 (4.6) 3 (3.8)
 in vigorous activity .1 (.3) .2 (.7) .2 (.8) 0 (.1)
VO2 Max, ml/kg/min 20.4 (5.4) 19.2 (4.3) 20.5 (5.1) 19 (4.4)
Tobacco Use
 Never 18(60) 11(39.3) 7(25.9) 14(56)
 Current 3(10) 2(7.1) 3(11.1) 2(8)
 Former 9(30) 15(53.6) 17(63) 9(36)
Prevalent Disease
 Heart Failure 1(3.3) 2(7.1) 2(7.4) 0(0)
 Coronary artery disease 2(6.7) 2(7.1) 2(7.4) 0(0)
 Diabetes mellitus 7(23.3) 6(21.4) 7(25.9) 8(30.8)
 Hypertension 27(90) 26(92.9) 25(92.6) 22(88)

Continuous variables are presented as mean (±SD) or median (25th percentile, 75th percentile) and categorical variables as n (%).